GATM and nonpapillary renal cell carcinoma: The exact mechanism by which creatine or GATM-attenuated cancer growth and related to immunotherapy is still unclear; however, a possible tumor-suppressive role of GATM was supported by the fact that low expression of GATM was associated with poor survival of patients with ccRCC treated with ICIs (as shown in Figure 4D).